ScreenerHero

AFT AFT Pharmaceuticals Limited

NZX · NZ · Healthcare · Drug Manufacturers - General · aftpharm.com
—Mkt Cap: —P/E: —

AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers proprietary and in-licensed…

Industry Peers

Drug Manufacturers - General
Screen all
LLY
Eli Lilly and Company
$1.12TUSDP/E 40.5
JNJ
Johnson & Johnson
$610.38BUSDP/E 28.7
ABBV
AbbVie Inc.
$500.80BUSDP/E 80.1
RO
Roche Holding AG
$370.64BUSDP/E 25.2
ROP
Roche Holding AG
$364.40BUSDP/E 24.8
MRK
Merck & Co., Inc.
$358.21BUSDP/E 115.2
ROG
Roche Holding AG
$340.19BUSDP/E 22.7
NOVN
Novartis AG
$288.24BUSDP/E 24.0
NVS
Novartis AG
$285.83BUSDP/E 22.0
AZN
AstraZeneca PLC
$260.71BUSDP/E 25.2
AZN
AstraZeneca PLC
$260.59BUSDP/E 26.7
AZN
AstraZeneca PLC
$258.50BUSDP/E 23.9
AMGN
Amgen Inc.
$234.65BUSDP/E 26.1
AZN
AstraZeneca PLC
$260.87BUSDP/E 25.4
GILD
Gilead Sciences, Inc.
$195.13BUSD
NOVO-B
Novo Nordisk A/S
$174.33BUSDP/E 10.1
NVO
Novo Nordisk A/S
$173.08BUSDP/E 9.6
PFE
Pfizer Inc.
$167.80BUSDP/E 38.7
BMY
Bristol-Myers Squibb Company
$123.73BUSDP/E 12.8
GSK
GSK plc
$98.21BUSDP/E 14.9

Key Statistics

Company
Market Cap—
Enterprise Value282.31M USD
Revenue (TTM)142.65M USD
Gross Profit59.95M USD
Net Income (TTM)8.25M USD
Revenue/Share2.43 NZD
Last Price—
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees126
CountryNZ
SectorHealthcare
IndustryDrug Manufacturers - General
ISINNZAFTE0001S4
Valuation
P/E (Trailing)—
P/E (Forward)18.81
PEG—
EV/EBITDA20.27
EV/Revenue1.98
P/S1.83
P/B4.23
EPS (TTM)0.14
EPS (Forward)0.24
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin42.61%
Oper. Margin14.10%
EBITDA Margin9.76%
Profit Margin5.86%
ROE13.36%
ROA6.79%
Growth
Revenue Growth15.20%
Earnings Growth-16.50%
Cash Flow & Leverage
Operating CF-5.34M USD
CapEx (TTM)5.46M USD
FCF Margin-8.23%
FCF Yield—
Net Debt24.57M USD
Net Debt/EBITDA1.76
Balance Sheet
Debt/Equity0.49
Current Ratio2.24
Quick Ratio1.03
Book Value/Sh1.05 NZD
Cash/Share0.10 NZD
Dividends
Fwd Div Rate—
Trail. Div Rate0.03 NZD
Div. Yield0.56%
5Y Avg Yield—
Payout Ratio12.86%
Ex-Div DateJun 18, 2026
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.850 NZD
Target Range4.650 NZD – 5.050 NZD
# Analysts2
Ownership
Shares Out.104.87M
Float30.43M
Insiders77.64%
Institutions1.09%
Technical
SMA 504.395 NZD
SMA 2003.892 NZD
Beta0.47
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)21.64K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—